Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dynavax Technologies Corp (NASDAQ:DVAX)

During the Trading Day
29.07 +1.97 / +7.27%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
29.07 0.00 / 0.00%
 
Volume: 13.4K

Today’s Trading

Previous close27.10
Today’s open27.55
Day’s range27.50 - 29.07
Volume287,539
Average volume (3 months)617,754
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)+5.60%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book7.10

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...+0.62+6.51%
TXMDTherapeuticsMD Inc+0.20+3.30%
RGENRepligen Corp+1.55+4.64%
ACHNAchillion Pharmaceut...+0.48+6.77%
Data as of 4:14pm ET, 09/02/2015

Financials

Next reporting dateOctober 29, 2015
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

Partner Offers